Description of Bausch Health Companies Inc's Business Segments

Bausch Health Companies Inc, formerly known as Valeant Pharmaceuticals International Inc, is a prominent multinational pharmaceutical and healthcare company that operates across multiple segments. The company is dedicated to improving patients lives through innovative products and services and has established a diversified portfolio that spans several therapeutic areas. Below is an extensive overview of the segments, products, and services that Bausch Health Companies Inc offers:

1. Eye Health
Bausch Health is recognized as a global leader in eye health, providing a comprehensive range of products tailored to meet the needs of vision caregivers and patients alike. Its offerings include:

- Prescription Medicines: These encompass treatments for various eye conditions, such as glaucoma, dry eye, and ocular inflammation. A notable product is Vyzulta, an ophthalmic solution designed to lower intraocular pressure in patients with glaucoma.

- Over-the-Counter Products: These products aid in managing common eye-related issues. Lumify, for instance, is a popular eye drop designed to reduce redness.

- Contact Lenses: The company offers an extensive array of contact lenses through its sophisticated brand, Soflens. These lenses provide comfort and clarity for a variety of vision correction needs.

- Lens Care Products: Bausch Health also markets lens care solutions, such as Biotrue Solutions, which are designed to maintain eye health and lens hygiene.

- Ophthalmic Surgical Devices: The company provides advanced surgical devices for eye surgery, contributing to improved surgical outcomes and patient safety.

Dermatology
In the dermatology segment, Bausch Health focuses on developing and marketing prescription products and consumer brands that address various skin conditions. Their portfolio includes:

- Prescription Medicines: Products such as Retin-A Micro, which is used to treat acne and reduce the appearance of fine lines, are central to their offerings.

- Acne Treatments: Bausch Healths AcneFree line provides a range of topical solutions to meet the needs of acne sufferers, offering formulas that are effective yet gentle on the skin.

- Skincare Products: Carpe is another brand under Bausch Health that specializes in sweat-absorbing products, enhancing comfort and confidence for consumers.

Gastrointestinal
Bausch Health’s gastrointestinal segment delivers essential therapies for managing a range of GI disorders. This segment features:

- Prescription Medications: Bausch Healths GI product lineup includes Xifaxan, Apriso, and Colazal, which are designed to treat conditions such as Crohns disease, ulcerative colitis, and irritable bowel syndrome. These medications focus on reducing inflammation and managing symptoms effectively.

- Specialty Products: Within this division, the company emphasizes its commitment to innovation in GI health, delivering therapies that improve patient outcomes and quality of life.

Consumer Health
The Consumer Health segment encompasses a variety of non-prescription products aimed at general wellness and specific health concerns. Key offerings include:

- Dietary Supplements: Bausch Health provides supplements that support overall health and wellness, catering to a range of consumer needs.

- Weight Loss Products: These products are designed to assist individuals in managing their weight effectively.

- Foot Care Products: The companys line of foot care solutions promotes comfort and addresses various foot-related issues.

- Popular Brands: Notable products such as BioTrue Contact Lens Solution and OXY Skincare are widely recognized, with BioTrue supporting contact lens wearers and OXY targeting acne treatment.

Salix Pharmaceuticals
Salix, a division of Bausch Health, is dedicated to developing innovative therapeutic options for gastrointestinal diseases. Key aspects include:

- Leader in GI Medicine: Salix is recognized for its extensive understanding and expertise in gastroenterology, focusing on advanced treatments for conditions like ulcerative colitis and Crohns disease.

- Therapeutic Products: The division offers a robust portfolio of proven therapies that effectively target various GI conditions. Each product is designed to enhance patient quality of life through targeted action and effective symptom management.

Summary
Bausch Health Companies Inc operates within a diverse array of healthcare sectors, emphasizing eye health, dermatology, gastrointestinal care, consumer health, and specialized therapies through Salix. The company is committed to enhancing patient care and outcomes through innovative products and dedicated research, making it a trusted name in both prescription and consumer healthcare markets. The products are designed to address specific health concerns and have earned the trust of healthcare professionals and patients globally.

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Composition of Bausch Health Companies Inc Revenues by Segments


Product sales	99.05 %	of total Revenue
Other revenues	0.95 %	of total Revenue
Segment	100 %	of total Revenue
Salix	25.32 %	of total Revenue
Salix Product sales	1.86 %	of total Revenue
International	11.29 %	of total Revenue
International Product sales	4.44 %	of total Revenue
International Other revenues	0.63 %	of total Revenue
Solta Medical	6.77 %	of total Revenue
Solta Medical Product sales	2.1 %	of total Revenue
Diversified	7.33 %	of total Revenue
Diversified Product sales	1.07 %	of total Revenue
Bausch Lomb	49.29 %	of total Revenue
Bausch Lomb Product sales	19.1 %	of total Revenue
Bausch Lomb Other revenues	0.04 %	of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments	Revenues (in millions $)	% (of total Revenues)
Product sales	2,500.00	99.05 %
Other revenues	24.00	0.95 %
Segment	2,524.00	100 %
Salix	639.00	25.32 %
Salix Product sales	47.00	1.86 %
International	285.00	11.29 %
International Product sales	112.00	4.44 %
International Other revenues	16.00	0.63 %
Solta Medical	171.00	6.77 %
Solta Medical Product sales	53.00	2.1 %
Diversified	185.00	7.33 %
Diversified Product sales	27.00	1.07 %
Bausch Lomb	1,244.00	49.29 %
Bausch Lomb Product sales	482.00	19.1 %
Bausch Lomb Other revenues	1.00	0.04 %
Total	2,524.00	100 %

Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment	Y/Y Revenue %	Q/Q Revenue %
Product sales	12.26 %	-
Other revenues	-25 %	-
Segment	11.73 %	-
Salix	17.9 %	-
Salix Product sales	9.3 %	-
International	8.78 %	-
International Product sales	9.8 %	-
International Other revenues	-5.88 %	-
Solta Medical	51.33 %	-
Solta Medical Product sales	96.3 %	-
Diversified	-9.76 %	-
Diversified Product sales	-10 %	-
Bausch Lomb	9.41 %	-
Bausch Lomb Product sales	0.21 %	-
Bausch Lomb Other revenues	0 %	-
Total	11.73 %	-75.41 %

Q1 three months ended (Mar 31 2026)
Income by Business Segments	Income (in millions $)	% (Profit Margin)
Total	-1,431.00	-

Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment	Y/Y Income %	Q/Q Income %
Total	-	-

Annual Report on Bausch Health Companies Inc Divisions, Sales by Country


Product sales	98.93 %	of total Revenue
Other revenues	1.07 %	of total Revenue
Salix	25.11 %	of total Revenue
Salix Product sales	1.68 %	of total Revenue
International	11.03 %	of total Revenue
International Product sales	4.64 %	of total Revenue
International Other revenues	0.57 %	of total Revenue
Solta Medical	5.05 %	of total Revenue
Solta Medical Product sales	1.26 %	of total Revenue
Diversified	9.13 %	of total Revenue
Diversified Product sales	1.24 %	of total Revenue
Bausch Lomb	49.69 %	of total Revenue
Bausch Lomb Product sales	19.92 %	of total Revenue
Bausch Lomb Other revenues	0.05 %	of total Revenue
Price Appreciation Credit	0.18 %	of total Revenue
Returns	1.22 %	of total Revenue
Pharmaceuticals	46.24 %	of total Revenue
Devices	23.76 %	of total Revenue
OTC	19.56 %	of total Revenue
Branded and Other generics	9.37 %	of total Revenue
Salix Pharmaceuticals	25.11 %	of total Revenue
International Pharmaceuticals	2.43 %	of total Revenue
International OTC	1.64 %	of total Revenue
International Branded and Other generics	6.25 %	of total Revenue
Solta Medical Devices	5.04 %	of total Revenue
Solta Medical Other revenues	0.01 %	of total Revenue
Diversified Pharmaceuticals	8.17 %	of total Revenue
Diversified OTC	0.06 %	of total Revenue
Diversified Branded and Other generics	0.75 %	of total Revenue
Diversified Other revenues	0.15 %	of total Revenue
Bausch Lomb Pharmaceuticals	10.53 %	of total Revenue
Bausch Lomb Devices	18.72 %	of total Revenue
Bausch Lomb OTC	17.86 %	of total Revenue
Bausch Lomb Branded and Other generics	2.37 %	of total Revenue
U S	59.79 %	of total Revenue
China	4.8 %	of total Revenue
Canada	4.06 %	of total Revenue
Poland	3.72 %	of total Revenue
Mexico	2.71 %	of total Revenue
France	2.43 %	of total Revenue
South Korea	2.28 %	of total Revenue
Russia	1.93 %	of total Revenue
Japan	1.87 %	of total Revenue
Germany	1.71 %	of total Revenue
United Kingdom	1.37 %	of total Revenue
Spain	1.06 %	of total Revenue
Italy	1.03 %	of total Revenue
Other	11.23 %	of total Revenue

Twelve months ended 2025
BHC s Annual Revenue by Geography and Business Segments	Sales (in millions $)	% (of total Sales)
Product sales	10,156.00	98.93 %
Other revenues	110.00	1.07 %
Salix	2,578.00	25.11 %
Salix Product sales	172.00	1.68 %
International	1,132.00	11.03 %
International Product sales	476.00	4.64 %
International Other revenues	59.00	0.57 %
Solta Medical	518.00	5.05 %
Solta Medical Product sales	129.00	1.26 %
Diversified	937.00	9.13 %
Diversified Product sales	127.00	1.24 %
Bausch Lomb	5,101.00	49.69 %
Bausch Lomb Product sales	2,045.00	19.92 %
Bausch Lomb Other revenues	5.00	0.05 %
Total	10,266.00	100 %
Price Appreciation Credit	18.00	0.18 %
Returns	125.00	1.22 %
Pharmaceuticals	4,747.00	46.24 %
Devices	2,439.00	23.76 %
OTC	2,008.00	19.56 %
Branded and Other generics	962.00	9.37 %
Salix Pharmaceuticals	2,578.00	25.11 %
International Pharmaceuticals	249.00	2.43 %
International OTC	168.00	1.64 %
International Branded and Other generics	642.00	6.25 %
Solta Medical Devices	517.00	5.04 %
Solta Medical Other revenues	1.00	0.01 %
Diversified Pharmaceuticals	839.00	8.17 %
Diversified OTC	6.00	0.06 %
Diversified Branded and Other generics	77.00	0.75 %
Diversified Other revenues	15.00	0.15 %
Bausch Lomb Pharmaceuticals	1,081.00	10.53 %
Bausch Lomb Devices	1,922.00	18.72 %
Bausch Lomb OTC	1,834.00	17.86 %
Bausch Lomb Branded and Other generics	243.00	2.37 %
U S	6,138.00	59.79 %
China	493.00	4.8 %
Canada	417.00	4.06 %
Poland	382.00	3.72 %
Mexico	278.00	2.71 %
France	249.00	2.43 %
South Korea	234.00	2.28 %
Russia	198.00	1.93 %
Japan	192.00	1.87 %
Germany	176.00	1.71 %
United Kingdom	141.00	1.37 %
Spain	109.00	1.06 %
Italy	106.00	1.03 %
Other	1,153.00	11.23 %

Twelve months ended 2025
BHC s Annual Income by Country and Business Segments	Income (in millions $)	% (Profit Margin)
Salix	1,925.00	74.67 %
International	334.00	29.51 %
Solta Medical	232.00	44.79 %
Diversified	627.00	66.92 %
Total	120.00	1.17 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments	% Y/Y Sales Growth	% Y/Y Income Growth
Product sales	6.7 %	-
Other revenues	2.8 %	-
Salix	10.5 %	20.16 %
Salix Product sales	-1.15 %	-
International	1.89 %	-11.17 %
International Product sales	6.01 %	-
International Other revenues	22.92 %	-
Solta Medical	17.73 %	8.92 %
Solta Medical Product sales	31.63 %	-
Diversified	-1.37 %	0.16 %
Diversified Product sales	-9.29 %	-
Bausch Lomb	6.47 %	-
Bausch Lomb Product sales	9.48 %	-
Bausch Lomb Other revenues	25 %	-
Total	6.66 %	-
Price Appreciation Credit	0 %	-
Returns	-21.88 %	-
Pharmaceuticals	7.98 %	-
Devices	8.88 %	-
OTC	5.52 %	-
Branded and Other generics	-1.74 %	-
Salix Pharmaceuticals	10.64 %	-
International Pharmaceuticals	0.4 %	-
International OTC	-2.89 %	-
International Branded and Other generics	2.88 %	-
Solta Medical Devices	17.5 %	-
Solta Medical Other revenues	0 %	-
Diversified Pharmaceuticals	-1.18 %	-
Diversified OTC	0 %	-
Diversified Branded and Other generics	4.05 %	-
Diversified Other revenues	-28.57 %	-
Bausch Lomb Pharmaceuticals	11.56 %	-
Bausch Lomb Devices	6.78 %	-
Bausch Lomb OTC	6.38 %	-
Bausch Lomb Branded and Other generics	-13.52 %	-
U S	6.43 %	-
China	-0.6 %	-
Canada	3.73 %	-
Poland	9.14 %	-
Mexico	-11.75 %	-
France	8.26 %	-
South Korea	60.27 %	-
Russia	22.98 %	-
Japan	2.13 %	-
Germany	10.69 %	-
United Kingdom	4.44 %	-
Spain	10.1 %	-
Italy	12.77 %	-
Other	6.46 %	-
Salix Other revenues	-	-
U S and Puerto Rico	-	-

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.